The research base is, in effect, the output of one laboratory and its collaborators over thirty years
Phase 3 TRIUMPH-4 (NCT05931367) reported 28.7% body weight loss at 12 mg, 26.4% at 9 mg, vs 2.1% placebo at 68 weeks
It was found that both AOD9604 and hGH resulted in fat loss in association with increased fat oxidation as well as increased levels of glycerol (relating to lipolysis), However, an added benefit of AOD9604 was that it did not lead to hyperglycemia in the mice or reduced insulin sensitivity
Materials and methods Reagents The peptides (CKPV) 2 and -MSH [113], N-acetylated and C-amidated, were kindly provided by Paolo Grieco, Department of Pharmaceutical and Toxicological Chemistry, University of Naples Federico II, Italy
Transwell assay The chemotactic motility of HUVECs was determined using transwell migration chambers (Corning) with 6.5 mm diameter polycarbonate filters (8 m pore size), as described previously
Our goal is not to be the cheapest research supplier it is to provide professionally handled compounds with real quality oversight and transparent testing context behind them